JYSB2500240 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2025-10-10 | | Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG | | | view |
CYSB2400023 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-01-23 | | Hisun Biopharmaceutical Co Ltd | | | view |
JYSZ2100520 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2021-06-10 | | Abbvie Ltd;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd | | | view |
JYSB2101038 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-02 | | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | | | view |
CYSB2400155 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-06-18 | | Hisun Biopharmaceutical Co Ltd | | | view |
JYSB2101202 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-12-22 | | Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG | | | view |
JYSB2500184 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2025-08-15 | | Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG | | | view |
CYSB2300080 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2023-04-11 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
JYSB2101039 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-02 | | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | | | view |
CYSB2200090 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group;Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
JYSB2500243 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2025-10-10 | | Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG | | | view |
CYSB2400050 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-02-29 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
CYSB2200048 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-16 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
JYSB2101060 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG | | | view |
CXSS2400138 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | New Drug Application | 2024-12-14 | | Zhejiang HUAHAI Biopharmaceuticals Co Ltd | | | view |
CYSB2200049 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-16 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CYSB2400125 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-22 | | SinoCelltech Ltd | | | view |
JYSB2200014 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-01-27 | | Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG | | | view |
CYSB2500144 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | Supplementary Application | 2025-07-01 | | Mabwell (Shanghai) Bioscience Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd | | | view |
CYSB2300050 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.3) | Supplementary Application | 2023-02-23 | | Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd | | | view |